{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:12:16Z","timestamp":1761707536483},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T00:00:00Z","timestamp":1032393600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/1471-2458-2-22","type":"journal-article","created":{"date-parts":[[2002,9,28]],"date-time":"2002-09-28T11:09:37Z","timestamp":1033211377000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["The average cost of measles cases and adverse events following vaccination in industrialised countries"],"prefix":"10.1186","volume":"2","author":[{"given":"H\u00e9l\u00e8ne","family":"Carabin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"John Edmunds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulla","family":"Kou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"van den Hof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Van","family":"Hung Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,9,19]]},"reference":[{"key":"39_CR1","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1093\/oxfordjournals.aje.a010145","volume":"151","author":"G De Serres","year":"2000","unstructured":"De Serres G, Gay NJ, Farrington CP: Epidemiology of transmissible disease after elimination. Am J Epidemiol. 2000, 151: 1039-48.","journal-title":"Am J Epidemiol"},{"key":"39_CR2","first-page":"4","volume-title":"Eurosurveillance Weekly","author":"M Cronin","year":"2000","unstructured":"Cronin M, Fitzsimmons GJ: Measles outbreak in the Republic of Ireland: update. Eurosurveillance Weekly. 2000, 4-"},{"key":"39_CR3","doi-asserted-by":"crossref","unstructured":"Outbreak of measles in an army base in Germany. Eurosurveillance Weekly. 2001, 5-","DOI":"10.2807\/esw.05.24.01735-en"},{"key":"39_CR4","unstructured":"Measles outbreak, Netherlands. Wkly Epidemiol Rec. 2000, 75: 119-21."},{"key":"39_CR5","unstructured":"Measles outbreak \u2013 Netherlands, April 1999 \u2013 January 2000. MMWR Morb Mortal Wkly Rep. 2000, 49: 299-303."},{"key":"39_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/ije\/14.1.153","volume":"14","author":"JA Clarkson","year":"1985","unstructured":"Clarkson JA, Fine PE: The efficiency of measles and pertussis notification in England and Wales. Int J Epidemiol. 1985, 14: 153-68.","journal-title":"Int J Epidemiol"},{"key":"39_CR7","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2307\/4593651","volume":"84","author":"NW Axnick","year":"1969","unstructured":"Axnick NW, Shavell SM, Witte JJ: Benefits due to immunization against measles. Public Health Rep. 1969, 84: 673-80.","journal-title":"Public Health Rep"},{"key":"39_CR8","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.2105\/AJPH.83.7.1011","volume":"83","author":"SF Davis","year":"1993","unstructured":"Davis SF, Strebel PM, Atkinson WL, et al: Reporting efficiency during a measles outbreak in New York City, 1991. Am J Public Health. 1993, 83: 1011-5.","journal-title":"Am J Public Health"},{"key":"39_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1071\/NB94021","volume":"5","author":"IF McDonnell","year":"1994","unstructured":"McDonnell IF, Jorm LR: Measles epidemic in western Sydney. New South Wales Public Health Bulletin. 1994, 5: 59-60.","journal-title":"New South Wales Public Health Bulletin"},{"key":"39_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/bmj.2.5401.75","volume":"2","author":"DL Miller","year":"1964","unstructured":"Miller DL: Frequency of complications of measles, 1963. Report on a National inquiry by the Public Health Laboratory Service in Collaboration with the society of medical officers of health. Br Med J. 1964, 2: 75-8.","journal-title":"Br Med J"},{"key":"39_CR11","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1136\/bmj.1.6122.1253","volume":"1","author":"CL Miller","year":"1978","unstructured":"Miller CL: Severity of notified measles. Br Med J. 1978, 1: 1253-5.","journal-title":"Br Med J"},{"key":"39_CR12","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/ije\/28.3.558","volume":"28","author":"P Godoy","year":"1999","unstructured":"Godoy P, Dominguez A, Alvarez J, et al: Measles epidemiology in Catalonia (Spain): implications for a regional vaccination programme. Int J Epidemiol. 1999, 28: 558-62. 10.1093\/ije\/28.3.558.","journal-title":"Int J Epidemiol"},{"key":"39_CR13","first-page":"2529","volume":"145","author":"S van den Hof","year":"2001","unstructured":"van den Hof S, van den Kerkhof JH, ten Ham PB, van Binnendijk RS, Conyn-van Spaendonck MA, van Steenbergen JE: [Measles epidemic in the Netherlands, 1999\u20132000]. Ned Tijdschr Geneesk. 2001, 145: 2529-33.","journal-title":"Ned Tijdschr Geneesk"},{"key":"39_CR14","volume-title":"Personal Communication","author":"K Grimsrud","year":"2001","unstructured":"Grimsrud K: Cases of measles in the Alberta's (Canada) outbreak. Personal Communication. 2001"},{"key":"39_CR15","first-page":"180","volume":"17","author":"P Godoy","year":"1999","unstructured":"Godoy P, Dominguez A, Camps N, et al: [Validity of the notifications of red measles based on clinical diagnosis in Cataluna, Spain]. Enfermedades Infecciosas y Microbiologia Clinica. 1999, 17: 180-3.","journal-title":"Enfermedades Infecciosas y Microbiologia Clinica"},{"key":"39_CR16","first-page":"455","volume":"159","author":"LG Dales","year":"1993","unstructured":"Dales LG, Kizer KW, Rutherford GW, Pertowski CA, Waterman SH, Woodford G: Measles epidemic from failure to immunize. West J Med. 1993, 159: 455-64.","journal-title":"West J Med"},{"key":"39_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1017\/S0950268899004525","volume":"125","author":"B Hanratty","year":"2000","unstructured":"Hanratty B, Holt T, Duffell E, et al: UK measles outbreak in non-immune anthroposophic communities: the implications for the elimination of measles from Europe. Epidemiol Infect. 2000, 125: 377-83. 10.1017\/S0950268899004525.","journal-title":"Epidemiol Infect"},{"key":"39_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/00006454-199301000-00010","volume":"12","author":"WH Mason","year":"1993","unstructured":"Mason WH, Ross LA, Lanson J, Wright HT: Epidemic measles in the postvaccine era: evaluation of epidemiology, clinical presentation and complications during an urban outbreak. Pediatr Infect Dis J. 1993, 12: 42-8.","journal-title":"Pediatr Infect Dis J"},{"key":"39_CR19","first-page":"451","volume":"43","author":"I Loras-Duclaux","year":"1988","unstructured":"Loras-Duclaux I, David L, Peyramond D, Floret D, Lachaux A, Hermier M: [Epidemiological study and cost evaluation of measles in Lyons hospitals over a 5-year period]. P\u00e9diatrie. 1988, 43: 451-4.","journal-title":"P\u00e9diatrie"},{"key":"39_CR20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1467-842X.1998.tb01156.x","volume":"22","author":"A Shiell","year":"1998","unstructured":"Shiell A, Jorm LR, Carruthers R, Fitzsimmons GJ: Cost-effectiveness of measles outbreak intervention strategies. Aust N Z J Public Health. 1998, 22: 126-32.","journal-title":"Aust N Z J Public Health"},{"key":"39_CR21","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/sim.4780101111","volume":"10","author":"CP Farrington","year":"1991","unstructured":"Farrington CP: Subacute sclerosing panencephalitis in England and Wales: transient effects and risk estimates. Stat Med. 1991, 10: 1733-44.","journal-title":"Stat Med"},{"key":"39_CR22","first-page":"1","volume":"35","author":"N Madge","year":"1993","unstructured":"Madge N, Diamond J, Miller D, et al: The National Childhood Encephalopathy study: a 10-year follow-up. A report on the medical, social, behavioural and educational outcomes after serious, acute, neurological illness in early childhood. Dev Med Child Neurol. 1993, 35: 1-118.","journal-title":"Dev Med Child Neurol"},{"key":"39_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0920-1211(95)00007-W","volume":"21","author":"YM Hart","year":"1995","unstructured":"Hart YM, Shorvon SD: The nature of epilepsy in the general population. I. Characteristics of patients receiving medication fro epilepsy. Epilepsy Res. 1995, 21: 43-9. 10.1016\/0920-1211(95)00007-W.","journal-title":"Epilepsy Res"},{"key":"39_CR24","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1542\/peds.103.3.556","volume":"103","author":"H Carabin","year":"1999","unstructured":"Carabin H, Gyorkos TW, Soto JC, Penrod J, Joseph L, Collet J-P: Estimation of direct and indirect costs due to common infections in toddlers attending daycare centres. Pediatrics. 1999, 103: 556-64.","journal-title":"Pediatrics"},{"key":"39_CR25","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1136\/bmj.294.6586.1527","volume":"294","author":"A Hastings","year":"1987","unstructured":"Hastings A, Hostler A, Solen A: Measles: who pays the cost?. Br Med J (Clin Res Ed). 1987, 294: 1527-8.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"39_CR26","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/S0264-410X(01)00437-6","volume":"20","author":"M Brisson","year":"2002","unstructured":"Brisson M, Edmunds WJ: The cost-effectiveness of varicella vaccination in Canada. Vaccine. 2002, 20: 1113-25. 10.1016\/S0264-410X(01)00437-6.","journal-title":"Vaccine"},{"key":"39_CR27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2165\/00002018-199819060-00002","volume":"19","author":"P Duclos","year":"1998","unstructured":"Duclos P, Ward BJ: Measles vaccines: a review of adverse events. Drug Saf. 1998, 19: 435-54.","journal-title":"Drug Saf"},{"key":"39_CR28","volume-title":"Ottawa, Canadian Medical Association","author":"National Advisory Committee on Immunization","year":"1998","unstructured":"National Advisory Committee on Immunization: Canadian Immunization guide. Ottawa, Canadian Medical Association. 1998"},{"key":"39_CR29","volume-title":"Canberra, AGPS","author":"National Health and Medical Research Council","year":"2000","unstructured":"National Health and Medical Research Council: The Australian Immunisation Handbook. Canberra, AGPS. 2000"},{"key":"39_CR30","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1016\/S0140-6736(99)01239-8","volume":"353","author":"B Taylor","year":"1999","unstructured":"Taylor B, Miller E, Farrington CP, et al: Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet. 1999, 353: 2026-9. 10.1016\/S0140-6736(99)01239-8.","journal-title":"Lancet"},{"key":"39_CR31","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1136\/bmj.322.7284.460","volume":"322","author":"JA Kaye","year":"2001","unstructured":"Kaye JA, del Mar Melero-Montes M, Jick H: Mumps, measles and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ. 2001, 322: 460-3. 10.1136\/bmj.322.7284.460.","journal-title":"BMJ"},{"key":"39_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1081\/ADA-100103119","volume":"27","author":"B Strauss","year":"2001","unstructured":"Strauss B, Bigham M: Does measles-mumps-rubella (MMR) vaccination cause inflammatory bowel disease and autism?. Can Commun Dis Rep. 2001, 27: 65-72. 10.1081\/ADA-100103119.","journal-title":"Can Commun Dis Rep"},{"key":"39_CR33","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S0140-6736(05)60171-7","volume":"349","author":"D Miller","year":"1997","unstructured":"Miller D, Wadsworth J, Diamond J, Ross D: Measles vaccination and neurological events. Lancet. 1997, 349: 730-1.","journal-title":"Lancet"},{"key":"39_CR34","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1056\/NEJMoa003077","volume":"345","author":"WE Barlow","year":"2001","unstructured":"Barlow WE, Davis RL, Glasser JW, et al: The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med. 2001, 345: 656-61. 10.1056\/NEJMoa003077.","journal-title":"N Engl J Med"},{"key":"39_CR35","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1542\/peds.106.5.e62","volume":"106","author":"M Virtanen","year":"2000","unstructured":"Virtanen M, Peltola H, Paunio M, Heinonen OP: Day-to-day reactogenecity and the healthy vaccinee effect of Measles-Mumps-Rubella Vaccination. Pediatrics. 2000, 106: e62-e68.","journal-title":"Pediatrics"},{"key":"39_CR36","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1542\/peds.100.5.767","volume":"100","author":"RL Davis","year":"1997","unstructured":"Davis RL, Marcuse E., Black S, et al: MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project. The Vaccine Safety Datalink Team. Pediatrics. 1997, 100: 767-71.","journal-title":"Pediatrics"},{"key":"39_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0264-410X(00)00154-7","volume":"19","author":"T Lieu","year":"2000","unstructured":"Lieu T, Black SB, Ray GT, Martin KE, Shinefield HR, Weniger BG: The hidden costs of infant vaccination. Vaccine. 2000, 19: 33-41. 10.1016\/S0264-410X(00)00154-7.","journal-title":"Vaccine"},{"key":"39_CR38","volume-title":"Canterbury, Personal Social Services Research Unit","author":"A Netten","year":"2000","unstructured":"Netten A, Curtis L: Unit costs for health and social care 2000. Canterbury, Personal Social Services Research Unit. 2000"},{"key":"39_CR39","volume-title":"Edmonton, Institute of Health Economics","author":"Institute of Health Economics","year":"2000","unstructured":"Institute of Health Economics: A national list of provincial costs for health costs: 1997\/8. Edmonton, Institute of Health Economics. 2000"},{"key":"39_CR40","volume-title":"Amsterdam, Statistics Netherlands","author":"Statistics Netherlands","year":"2001","unstructured":"Statistics Netherlands: Income, wage, labour costs and working hours of employees. Amsterdam, Statistics Netherlands. 2001, [http:\/\/www.cbs.nl\/en\/figures\/keyfigures\/sip_400z.htm]"},{"key":"39_CR41","volume-title":"London: National Statistics. The official UK statistics site","author":"National Statistics","year":"2001","unstructured":"National Statistics: New Earning Survey 2000. Average weekly Earnings. London: National Statistics. The official UK statistics site. 2001, [http:\/\/www.statistics.gov.uk\/statbase\/xsdataset.asp]"},{"key":"39_CR42","volume-title":"Ottawa: Statistics Canada","author":"Statistics Canada","year":"2001","unstructured":"Statistics Canada: Ottawa: Statistics Canada. 2001, [http:\/\/www.statcan.ca\/english\/Pgdb\/People\/Labour\/labor01a.htm]"},{"key":"39_CR43","volume-title":"Paris: Organisation for Economic Co-Operation and Development (OECD)","author":"Organisation for Economic Co-Operation and Development (OECD)","year":"1998","unstructured":"Organisation for Economic Co-Operation and Development (OECD): Health Data 1998. Paris: Organisation for Economic Co-Operation and Development (OECD). 1998"},{"key":"39_CR44","volume-title":"Montreal: IMS Canada","author":"Canada IMS","year":"1999","unstructured":"IMS Canada: Retail pharmacy dispensed prescription costs: Canada and provinces. Montreal: IMS Canada. 1999"},{"key":"39_CR45","volume-title":"London: British National Formulary","author":"British National Formulary","year":"2001","unstructured":"British National Formulary: London: British National Formulary. 2001, [http:\/\/bnf.vhn.net\/home]"},{"key":"39_CR46","volume-title":"Boots","author":"Boots the Chemist","year":"2001","unstructured":"Boots the Chemist: Price of OTC drugs in the UK. Boots. 2001, [http:\/\/bnf.vhn.net\/home]"},{"key":"39_CR47","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0920-1211(00)00168-6","volume":"43","author":"DC Heany","year":"2001","unstructured":"Heany DC, Sander JWAS, Shorvon SD: Comparing the cost of epilepsy across eight European countries. Epilepsy Res. 2001, 43: 89-95. 10.1016\/S0920-1211(00)00168-6.","journal-title":"Epilepsy Res"},{"key":"39_CR48","unstructured":"Historical Currency Exchange Rates. OANDA. 2001, [http:\/\/www.oanda.com\/convert\/fxhistory]"},{"key":"39_CR49","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/oxfordjournals.aje.a009076","volume":"145","author":"MA Sanchez","year":"1997","unstructured":"Sanchez MA, Blower SM: Uncertainty and sensitivity analysis of the basic reproductive rate. Am J Epidemiol. 1997, 145: 1127-37.","journal-title":"Am J Epidemiol"},{"key":"39_CR50","volume-title":"New York (NY), Palisade Corporation","author":"@Risk","year":"2000","unstructured":"@Risk: Risk Analysis and simulation add-in for Excel (version 4). New York (NY), Palisade Corporation. 2000"},{"key":"39_CR51","first-page":"383","volume":"19","author":"DP Taracena","year":"1983","unstructured":"Taracena DP, Monton JL, Cristobal P, Gonzalez F, Casas J: [The cost of measles in Spain]. An Esp Pediatr. 1983, 19: 383-8.","journal-title":"An Esp Pediatr"},{"key":"39_CR52","volume-title":"Vaccine","author":"P Beutels","year":"2002","unstructured":"Beutels P, van Damme P, van Casteren V, Gay NJ, De Schrijver K, Meheus A: The difficult quest for data on \"vanishing\" vaccine-preventable infections in Europe: the case of measles in Flanders (Belgium). Vaccine. 2002,"},{"key":"39_CR53","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2105\/AJPH.75.7.739","volume":"75","author":"CC White","year":"1985","unstructured":"White CC, Koplan JP, Orenstein WA: Benefits, risks and costs of immunization for measles, mumps and rubella. Am J Public Health. 1985, 75: 739-44.","journal-title":"Am J Public Health"},{"key":"39_CR54","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/S0264-410X(97)00281-8","volume":"16","author":"L Pelletier","year":"1998","unstructured":"Pelletier L, Chung P, Duclos P, Manga P, Scott J: A benefit-cost analysis of two-dose measles immunization in Canada. Vaccine. 1998, 16: 989-96. 10.1016\/S0264-410X(97)00281-8.","journal-title":"Vaccine"},{"key":"39_CR55","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/S0264-410X(98)00125-X","volume":"16","author":"MA Miller","year":"1998","unstructured":"Miller MA, Redd S, Hadler S, Hinman A: A model to estimate the potential economic benefits of measles eradication for the United States. Vaccine. 1998, 16: 1917-22. 10.1016\/S0264-410X(98)00125-X.","journal-title":"Vaccine"},{"key":"39_CR56","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/140349487800600303","volume":"6","author":"M Ekblom","year":"1978","unstructured":"Ekblom M, Elo O, Laurinkari J, Niemela P: Costs and benefits of measles vaccination in Finland. Scand J Soc Med. 1978, 6: 111-5.","journal-title":"Scand J Soc Med"},{"key":"39_CR57","first-page":"273","volume":"43","author":"G Wiedermann","year":"1979","unstructured":"Wiedermann G, Ambrosch F: Cost-benefit calculations of vaccinations against measles and mumps in Austria. Dev Biol Stand. 1979, 43: 273-7.","journal-title":"Dev Biol Stand"},{"key":"39_CR58","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1542\/peds.76.4.524","volume":"76","author":"AB Bloch","year":"1985","unstructured":"Bloch AB, Orenstein WA, Stetler HC, et al: Health impact of measles vaccination in the United States. Pediatrics. 1985, 76: 524-32.","journal-title":"Pediatrics"},{"key":"39_CR59","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0264-410X(87)90058-2","volume":"5","author":"JL Carrasco","year":"1987","unstructured":"Carrasco JL, Lardinois R: Formula for calculating vaccine profitability. Vaccine. 1987, 5: 123-7. 10.1016\/0264-410X(87)90058-2.","journal-title":"Vaccine"},{"key":"39_CR60","first-page":"502","volume":"65","author":"A Moiraghi Ruggeni","year":"1986","unstructured":"Moiraghi Ruggeni A, Zotti Z, Pedronetto A, Milano R, Garella D, Sachetti C: I ricoveri ispedalieri in Torino per morbillo e relative complicanze nel periodo 1973\u20131983: valuazioni sanitarie ed economiche, in raporto alla opportunita dell'intervento vaccinale. Bol Ist Sieroterio Milano. 1986, 65: 502-11.","journal-title":"Bol Ist Sieroterio Milano"},{"key":"39_CR61","volume-title":"Arlington, VA: Center for Disease Control and Prevention","author":"E Hatziandreu","year":"1994","unstructured":"Hatziandreu E, Halpern NT, Brown RE, Watson GA: Cost-benefit analysis of the measles-mumps-rubella (MMR) vaccine. Arlington, VA: Center for Disease Control and Prevention. 1994"},{"key":"39_CR62","volume-title":"Atlanta: Center for Disease Control and Prevention","author":"Center for Disease Control and Prevention","year":"1977","unstructured":"Center for Disease Control and Prevention: Public attitudes towards immunization. Atlanta: Center for Disease Control and Prevention. 1977"},{"key":"39_CR63","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/ije\/21.5.998","volume":"21","author":"C Miller","year":"1992","unstructured":"Miller C, Farrington CP, Harbert K: The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970\u20131989. Int J Epidemiol. 1992, 21: 998-1006.","journal-title":"Int J Epidemiol"},{"key":"39_CR64","volume-title":"Personal communications","author":"S van den Hof","year":"2001","unstructured":"van den Hof S: Costs of measles in the Netherlands. Personal communications. 2001"},{"key":"39_CR65","first-page":"81","volume":"42","author":"ANK Cope","year":"1993","unstructured":"Cope ANK, Frank PF, Montgomery J, et al: Measles\u2013Duval County, Florida, 1991\u20131992. Morb Mortal Wkly Rep. 1993, 42: 81-3.","journal-title":"Morb Mortal Wkly Rep"},{"key":"39_CR66","first-page":"270","volume":"10","author":"O Mansoor","year":"1997","unstructured":"Mansoor O: Vaccine adverse events reported in New Zealand 1990\u20135. N Z Med J. 1997, 10: 270-2.","journal-title":"N Z Med J"},{"key":"39_CR67","first-page":"20","volume":"165","author":"G Chavez","year":"1996","unstructured":"Chavez G, Ellis A: Pediatric hospital admissions for measles. Lessons from the 1990 epidemic. West J Med. 1996, 165: 20-25.","journal-title":"West J Med"},{"key":"39_CR68","first-page":"117","volume":"21","author":"A Bentsi-Enchill","year":"1995","unstructured":"Bentsi-Enchill A, Hardy M, Koch J, Duclos P: Adverse events temporally associated with vaccines \u2013 1992 report. Can Commun Dis Rep. 1995, 21: 117-128.","journal-title":"Can Commun Dis Rep"},{"key":"39_CR69","first-page":"27","volume":"24","author":"RM D'Souza","year":"2000","unstructured":"D'Souza RM, Campbell-Lloyd S, Isaacs D, et al: Adverse events following immunisation associated with the 1998 Australian measles control campaign. Commun Dis Intell. 2000, 24: 27-33.","journal-title":"Commun Dis Intell"},{"key":"39_CR70","volume-title":"London: Department of Health","author":"Department of Health","year":"1995","unstructured":"Department of Health: Measles Rubella (MR) Immunisation Campaign in England 1994. One Year On. London: Department of Health. 1995"},{"key":"39_CR71","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1097\/00006454-200012000-00002","volume":"19","author":"A Patja","year":"2000","unstructured":"Patja A, Davidkin I, Kurki T, Kallio MJ, Valle M, Peltola H: Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J. 2000, 19: 1127-34.","journal-title":"Pediatr Infect Dis J"},{"key":"39_CR72","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0264-410X(91)90053-9","volume":"9","author":"RT Chen","year":"1991","unstructured":"Chen RT, Moses JM, Markowitz LE, Orenstein WA: Adverse events following measles-mumps-rubella and measles vaccinations in college students. Vaccine. 1991, 9: 297-9. 10.1016\/0264-410X(91)90053-9.","journal-title":"Vaccine"},{"key":"39_CR73","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1136\/bmj.310.6995.1629","volume":"310","author":"RJ Roberts","year":"1995","unstructured":"Roberts RJ, Sandifer QD, Evans MR, Nolan-Farrell MZ, Davis PM: Reasons for non-uptake of measles, mumps, and rubella catch up immunisation in a measles epidemic and side effects of the vaccine. BMJ. 1995, 310: 1629-32.","journal-title":"BMJ"},{"key":"39_CR74","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.2105\/AJPH.85.12.1706","volume":"85","author":"S Rosenthal","year":"1995","unstructured":"Rosenthal S, Chen R: The reporting sensitivities of two passive surveillance systems for vaccine adverse events. Am J Public Health. 1995, 85: 1706-9.","journal-title":"Am J Public Health"},{"key":"39_CR75","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1542\/peds.88.5.881","volume":"88","author":"MR Griffin","year":"1991","unstructured":"Griffin MR, Ray WA, Mortimer EA, Fenichel GM, Schaffner W: Risk of seizures after measles-mumps-rubella immunization. Pediatrics. 1991, 88: 881-5.","journal-title":"Pediatrics"},{"key":"39_CR76","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/ije\/18.3.684","volume":"18","author":"Y Okuno","year":"1989","unstructured":"Okuno Y, Nakao T, Ishida N, et al: Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan. Int J Epidemiol. 1989, 18: 684-9.","journal-title":"Int J Epidemiol"},{"key":"39_CR77","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/00006454-199601000-00010","volume":"15","author":"AP Jonville-Bera","year":"1996","unstructured":"Jonville-Bera AP, Autret E, Galy-Eyraud C, Hessel L: Thrombocytopenic purpura after measles, mumps and rubella vaccination: a retrospective survey by the French regional pharmacovigilance centres and pasteur-merieux serums and vaccines. Pediatr Infect Dis J. 1996, 15: 44-8. 10.1097\/00006454-199601000-00010.","journal-title":"Pediatr Infect Dis J"},{"key":"39_CR78","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/adc.84.3.227","volume":"84","author":"E Miller","year":"2001","unstructured":"Miller E, Waight P, Farrington CP: Idiopathic thrombocytopenic purpura and MMR vaccine. Arch Dis Child. 2001, 84: 227-9. 10.1136\/adc.84.3.227.","journal-title":"Arch Dis Child"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-2-22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-2-22\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-2-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-2-22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:36:35Z","timestamp":1726245395000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-2-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9,19]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2002,12]]}},"alternative-id":["39"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-2-22","relation":{},"ISSN":["1471-2458"],"issn-type":[{"type":"electronic","value":"1471-2458"}],"subject":[],"published":{"date-parts":[[2002,9,19]]},"assertion":[{"value":"25 July 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"22"}}